IKERVIS (Seqirus Pty Ltd)
Product name
IKERVIS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
206 working days (225)
Active ingredients
ciclosporin
Registration type
EOI
Indication
IKERVIS (eye drops) is indicated for the treatment of severe keratitis in adult patients with dry eye disease which has not improved despite treatment with tear substitutes.